Summary
The product Masteron Enanthate 200 mg/ml, manufactured by PrimePharma, was analyzed to verify its composition and dosage accuracy. The sample, identified by batch number PP1772, was submitted by the reseller Opitropin.EU and tested by Janoshik Analytical, a laboratory recognized for pharmaceutical quality control. The analysis confirmed the presence of Drostanolone Enanthate with a measured concentration of 211.63 mg/ml, exceeding the labeled specification of 200 mg/ml by 5.82%.
The testing process began on 2 May 2023, with the sample received on 11 May 2023, and the analysis completed on 15 May 2023. The submission by a reseller underscores the need for scrutiny, as such samples are often selected from optimal batches and may not represent the broader market. Additional independent testing is recommended to validate the consistency of the product across different batches.
This report is intended to provide educational insights and promote harm reduction within the anabolic steroid market.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Masteron Enanthate 200 mg/ml
- Active Ingredient: Drostanolone Enanthate
- Batch Number: PP1772
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29403
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Labeled Specification: 200 mg/ml
- Measured Concentration: 211.63 mg/ml
- Accuracy: 105.82% (5.82% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/29403_2AL4IUYAJX6V
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
The accuracy of the results reflects positively on this batch of Masteron Enanthate 200 mg/ml. However, since the sample was submitted and funded by a reseller, Opitropin.EU, it is essential to approach the findings with a degree of scrutiny. Resellers may select high-quality batches for analysis, which could present an overly favorable view of product quality. While Janoshik Analytical is a reputable and independent testing laboratory, further validation through independent third-party testing would strengthen consumer confidence and verify consistency across multiple batches.
Conclusion
The analysis of Masteron Enanthate 200 mg/ml confirms that this product is slightly overdosed, with a concentration of 211.63 mg/ml, exceeding its label claim by 5.82%. These findings suggest that the product meets high-quality standards, though independent testing is advised to ensure consistency across the market. This report serves as a resource for harm reduction, helping individuals make informed decisions about the quality of anabolic steroid products.
Disclaimer: This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
